Posterior Reversible Encephalopathy Syndrome in a Pediatric COVID-19 Patient

Pediatr Infect Dis J. 2021 Jun 1;40(6):e240-e242. doi: 10.1097/INF.0000000000003130.


Novel coronavirus disease 2019 is a viral infectious disease which commonly involve the lungs with primarily radiologic manifestations of atypical or organizing pneumonia. It can cause multisystemic involvement including central nervous system symptoms. One of these neurologic manifestations is posterior reversible encephalopathy syndrome (PRES). It is suggested that the increased levels of cytokines and inflammatory mediators in the course of the disease are responsible for cerebrovascular endothelial dysfunction and disruption of the blood-brain barrier. To the best of our knowledge, no pediatric PRES has been reported related to coronavirus disease 2019. Here, we present a pediatric PRES case associated with severe acute respiratory syndrome coronavirus 2 infection.

Publication types

  • Case Reports

MeSH terms

  • Blood-Brain Barrier
  • COVID-19 / complications*
  • COVID-19 / diagnostic imaging
  • COVID-19 / immunology
  • COVID-19 / virology
  • Child
  • Cytokines / immunology
  • Hospitalization
  • Humans
  • Lung / diagnostic imaging
  • Male
  • Posterior Leukoencephalopathy Syndrome / diagnostic imaging*
  • Posterior Leukoencephalopathy Syndrome / immunology
  • Posterior Leukoencephalopathy Syndrome / virology*
  • SARS-CoV-2 / isolation & purification


  • Cytokines